Study type

Study topic

Disease /health condition

Study type

Non-interventional study

Scope of the study

Effectiveness study (incl. comparative)
Other

If ‘other’, further details on the scope of the study

Overall survival in real world setting

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Medical condition to be studied

Colorectal cancer metastatic
Population studied

Short description of the study population

The target population was adults with mCRC who are eligible and willing to receive subsequent
treatment, having had two prior disease progressions since diagnosis of first metastasis.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

1000
Study design details

Study design

This was a prospective, observational, non-interventional, international multi-center, cohort study designed to collect data on patients with mCRC after two disease progressions since diagnosis of first metastasis that led to systemic treatment.

Main study objective

To describe the following for mCRC patients in a real world setting:
- Overall survival
- Treatment patterns for mCRC throughout the continuum of care
- Effectiveness/safety of treatments
- Reasons for therapy discontinuations and choice of subsequent treatment
- Adherence to National and European Guidelines
- Healthcare resource utilization
- Patient reported outcomes

Setting

The study was conducted in 18 countries. Investigators at academic or community based medical sites in the selected countries of interest that were experienced in the treatment and management of CRC and in conducting observational studies were approached for potential participation in the study.

Data analysis plan

descriptive statistics

Summary results

This large real world study helped define the current landscape of mCRC patients and therapy, and provided both clinical information and patient reported outcomes for a robust and complete profile of global mCRC management.